Syntax Research, Inc. Elevance Health, Inc. Transaction History
Syntax Research, Inc.
- $131 Billion
- Q1 2024
A detailed history of Syntax Research, Inc. transactions in Elevance Health, Inc. stock. As of the latest transaction made, Syntax Research, Inc. holds 36 shares of ELV stock, worth $19,245. This represents 0.01% of its overall portfolio holdings.
Number of Shares
36
Previous 36
-0.0%
Holding current value
$19,245
Previous $17.1 Million
10.31%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding ELV
# of Institutions
1,804Shares Held
198MCall Options Held
1.1MPut Options Held
1.08M-
Vanguard Group Inc Valley Forge, PA21.2MShares$11.4 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY20.9MShares$11.2 Billion0.26% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.7MShares$6.27 Billion0.74% of portfolio
-
State Street Corp Boston, MA10.5MShares$5.6 Billion0.25% of portfolio
-
Geode Capital Management, LLC Boston, MA4.69MShares$2.51 Billion0.23% of portfolio
About Elevance Health, Inc.
- Ticker ELV
- Exchange NYSE
- Sector Healthcare
- Industry Healthcare Plans
- Shares Outstandng 240,000,992
- Market Cap $128B
- Description
- Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....